GlassScriptPhysician profile
Kenneth Hamilton
NPI 1013987593
$7,747.09
in general payments reported to CMS, 2019-2025
41 companies · $510 in 2025
The $510 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,934 · 2020: $953 · 2021: $1,449 · 2022: $836 · 2023: $1,071 · 2024: $994 · 2025: $510.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,525 · Education: $50.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,524.76 |
| Education | $50.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,405.75 | 2019-2025 | Jardiance, Ofev |
| Novo Nordisk INC | $966.75 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Astrazeneca Pharmaceuticals LP | $605.09 | 2019-2025 | Airsupra, Breztri |
| Bayer Healthcare Pharmaceuticals INC. | $562.41 | 2021-2024 | |
| Glaxosmithkline, LLC. | $472.69 | 2019-2025 | Shingrix, Trelegy Ellipta, Arexvy |
| Amgen INC. | $395.89 | 2019-2025 | Repatha, Otezla, Repatha |
| Lilly USA, LLC | $300.52 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Sanofi-Aventis U.S. LLC | $273.90 | 2019-2021 | |
| Acacia Pharma INC | $239.90 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $225.43 | 2019 | |
| Pfizer INC. | $224.01 | 2019-2025 | |
| Nevro Corp. | $222.45 | 2023-2024 | Senza |
| Amarin Pharma, INC. | $220.77 | 2019-2021 | |
| Abbvie INC. | $208.35 | 2019-2023 | |
| Mylan Specialty L.P. | $188.05 | 2019-2023 | Yupelri |
Show all 41 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $161.23 | 2019-2023 | Xarelto |
| Astellas Pharma US INC | $127.29 | 2019-2023 | Veozah |
| Merck Sharp & Dohme LLC | $97.48 | 2020-2024 | Gardasil, Capvaxive, Gardasil 9 |
| Sanofi Pasteur INC. | $89.99 | 2019-2023 | |
| Novartis Pharmaceuticals Corporation | $85.28 | 2019-2023 | |
| Exact Sciences Corporation | $84.97 | 2023-2025 | Cologuard Collection Kit |
| Currax Pharmaceuticals LLC | $77.68 | 2023 | Nexletol, Contrave, Onzetra Xsail |
| Corcept Therapeutics | $57.20 | 2024 | Korlym |
| Kowa Pharmaceuticals America, INC. | $55.16 | 2019-2022 | |
| Radius Health, INC. | $46.27 | 2023-2024 | Tymlos |
| Sumitomo Pharma America, INC. | $44.36 | 2024 | Gemtesa |
| Sunovion Pharmaceuticals INC. | $41.03 | 2021 | |
| Allergan, INC. | $33.96 | 2020 | |
| Inspire Medical Systems, INC. | $28.86 | 2024 | Inspire |
| Ethicon US, LLC | $23.69 | 2019 | |
| Abbott Laboratories | $20.63 | 2024 | Freestyle Libre |
| Boston Scientific Corporation | $20.49 | 2025 | Watchman Flx |
| Globus Medical, INC. | $19.92 | 2025 | Omnia |
| Aimmune Therapeutics, INC. | $18.86 | 2024 | |
| Gilead Sciences, INC. | $17.43 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $17.18 | 2023 | Camzyos |
| Vistapharm, INC. | $14.38 | 2021 | |
| Horizon Therapeutics Plc | $13.80 | 2019 | |
| Si-Bone, INC. | $13.18 | 2021 | |
| Dexcom, INC. | $12.78 | 2020 | |
| Biogen, INC. | $12.03 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kenneth Hamilton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.